Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long lasting performance through its brands Greatbatch Medical and Electrochem. Over the last two years, the company has completed several strategic acquisitions that have expanded its product portfolio in both its medical and Electrochem markets.
In the medical device market, Greatbatch Medical has provided the most reliable underlying technologies for the top cardiac rhythm management (CRM) device manufacturers in the world for nearly 40 years. Today, with a broader offering, Greatbatch Medical continues to strengthen its performance by ensuring that customers can focus on what matters most to them: the advancement of medical technologies that contribute to the best outcomes possible for patients around the world. Greatbatch Medical follows through on its commitment to their success by providing supporting technologies and doing its part to facilitate new developments in CRM, neuromodulation, vascular access and orthopaedics.
A Legacy of Excellence - Wilson Greatbatch, co-inventor of the first successfully implanted pacemaker, founded Greatbatch, Inc. in 1970 to develop long-lived primary batteries to fuel pacemakers. His passion for reliability and innovation is the foundation for Greatbatch's full portfolio of capabilities and offerings. Greatbatch manufactures to customer and best practice specifications.
Strategic Initiatives - Greatbatch's financial performance is driven by its three strategic initiatives of growing and diversifying its revenue base, driving operating performance and delivering innovative solutions. Future growth will be driven by continued technology leadership, the company's strong product pipeline--including MRI compatible systems & components, Q series batteries and wireless sensing increasing market penetration, as well as further streamlining and optimizing its operations and business processes.
